SK134899A3 - Process for preparing o-(3-amino-2-hydroxy-propyl)hydroxymic acid halides - Google Patents
Process for preparing o-(3-amino-2-hydroxy-propyl)hydroxymic acid halides Download PDFInfo
- Publication number
- SK134899A3 SK134899A3 SK1348-99A SK134899A SK134899A3 SK 134899 A3 SK134899 A3 SK 134899A3 SK 134899 A SK134899 A SK 134899A SK 134899 A3 SK134899 A3 SK 134899A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- compounds
- amino
- reaction
- lines
- Prior art date
Links
- 239000002253 acid Substances 0.000 title claims abstract description 27
- 150000004820 halides Chemical class 0.000 title claims abstract description 16
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 44
- 150000001875 compounds Chemical class 0.000 claims abstract description 38
- -1 carboxamide oxime Chemical class 0.000 claims abstract description 26
- GMWFCJXSQQHBPI-UHFFFAOYSA-N azetidin-3-ol Chemical class OC1CNC1 GMWFCJXSQQHBPI-UHFFFAOYSA-N 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- 239000011541 reaction mixture Substances 0.000 claims abstract description 10
- 239000012954 diazonium Substances 0.000 claims abstract description 8
- 150000001989 diazonium salts Chemical class 0.000 claims abstract description 8
- 239000003960 organic solvent Substances 0.000 claims abstract description 8
- 235000010288 sodium nitrite Nutrition 0.000 claims abstract description 6
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims abstract description 5
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical class CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 claims abstract description 4
- 230000001476 alcoholic effect Effects 0.000 claims abstract description 4
- 229910001854 alkali hydroxide Inorganic materials 0.000 claims abstract description 4
- 239000002585 base Substances 0.000 claims abstract description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 4
- 239000011707 mineral Substances 0.000 claims abstract description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000012433 hydrogen halide Substances 0.000 claims abstract description 3
- 229910000039 hydrogen halide Inorganic materials 0.000 claims abstract description 3
- 150000001450 anions Chemical class 0.000 claims abstract 2
- 238000006243 chemical reaction Methods 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 27
- 239000003153 chemical reaction reagent Substances 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000000543 intermediate Substances 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- SFZULDYEOVSIKM-UHFFFAOYSA-N chembl321317 Chemical compound C1=CC(C(=N)NO)=CC=C1C1=CC=C(C=2C=CC(=CC=2)C(=N)NO)O1 SFZULDYEOVSIKM-UHFFFAOYSA-N 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 claims description 5
- 238000006193 diazotization reaction Methods 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 238000007086 side reaction Methods 0.000 claims description 4
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims description 3
- 239000006227 byproduct Substances 0.000 claims description 3
- 238000000354 decomposition reaction Methods 0.000 claims description 3
- 125000001188 haloalkyl group Chemical group 0.000 claims description 3
- 125000005842 heteroatom Chemical group 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 125000004076 pyridyl group Chemical group 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 125000001544 thienyl group Chemical group 0.000 claims description 3
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims 3
- 238000010934 O-alkylation reaction Methods 0.000 claims 2
- 238000005804 alkylation reaction Methods 0.000 claims 2
- 230000001419 dependent effect Effects 0.000 claims 2
- 238000000746 purification Methods 0.000 claims 2
- 238000003860 storage Methods 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 238000012360 testing method Methods 0.000 claims 2
- 230000001131 transforming effect Effects 0.000 claims 2
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims 1
- UFOZXNZOYKGSQO-UHFFFAOYSA-N 1-amino-3-aminooxypropan-2-ol Chemical compound NCC(O)CON UFOZXNZOYKGSQO-UHFFFAOYSA-N 0.000 claims 1
- 229910000831 Steel Inorganic materials 0.000 claims 1
- 238000007171 acid catalysis Methods 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- 150000004703 alkoxides Chemical class 0.000 claims 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical class C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 239000000539 dimer Substances 0.000 claims 1
- 150000004679 hydroxides Chemical class 0.000 claims 1
- 230000002427 irreversible effect Effects 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000012038 nucleophile Substances 0.000 claims 1
- 230000037361 pathway Effects 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 239000003586 protic polar solvent Substances 0.000 claims 1
- 238000004904 shortening Methods 0.000 claims 1
- 239000010959 steel Substances 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 230000009466 transformation Effects 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000001816 cooling Methods 0.000 description 5
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- FXNSRODXMVUCNJ-ODZAUARKSA-N (z)-but-2-enedioic acid;hydrochloride Chemical compound Cl.OC(=O)\C=C/C(O)=O FXNSRODXMVUCNJ-ODZAUARKSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- RPNGOMBXNOMBCG-BTJKTKAUSA-N (z)-but-2-enedioic acid;n-(2-hydroxy-3-piperidin-1-ylpropoxy)pyridine-3-carboximidoyl chloride Chemical compound OC(=O)\C=C/C(O)=O.C1CCCCN1CC(O)CON=C(Cl)C1=CC=CN=C1 RPNGOMBXNOMBCG-BTJKTKAUSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- WUHOOISVAOJLPM-UHFFFAOYSA-M 4-azoniaspiro[3.5]nonan-2-ol;chloride Chemical compound [Cl-].C1C(O)C[N+]21CCCCC2 WUHOOISVAOJLPM-UHFFFAOYSA-M 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- AQBMQGDKWIPBRF-UHFFFAOYSA-N n'-hydroxypyridine-3-carboximidamide Chemical compound ON=C(N)C1=CC=CN=C1 AQBMQGDKWIPBRF-UHFFFAOYSA-N 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 2
- ZYJPUMXJBDHSIF-NSHDSACASA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZYJPUMXJBDHSIF-NSHDSACASA-N 0.000 description 1
- IGMZDGBNMCELOE-UHFFFAOYSA-N 1-chloro-3-piperidin-1-ylpropan-2-ol Chemical compound ClCC(O)CN1CCCCC1 IGMZDGBNMCELOE-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 125000001711 D-phenylalanine group Chemical group [H]N([H])[C@@]([H])(C(=O)[*])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 201000002249 diabetic peripheral angiopathy Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- QKGYJVXSKCDGOK-UHFFFAOYSA-N hexane;propan-2-ol Chemical compound CC(C)O.CCCCCC QKGYJVXSKCDGOK-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- YHOHJGPFIWVLTP-UHFFFAOYSA-N n'-(2-hydroxy-3-piperidin-1-ylpropoxy)thiophene-2-carboximidamide;hydrochloride Chemical compound Cl.C1CCCCN1CC(O)CONC(=N)C1=CC=CS1 YHOHJGPFIWVLTP-UHFFFAOYSA-N 0.000 description 1
- JZHARKPIZHJQHA-UHFFFAOYSA-N n-(2-hydroxy-3-piperidin-1-ylpropoxy)-2-(trifluoromethyl)benzenecarboximidoyl chloride;hydrochloride Chemical compound Cl.C1CCCCN1CC(O)CON=C(Cl)C1=CC=CC=C1C(F)(F)F JZHARKPIZHJQHA-UHFFFAOYSA-N 0.000 description 1
- HPNBPCVAJIMXAR-UHFFFAOYSA-N n-(2-hydroxy-3-piperidin-1-ylpropoxy)benzenecarboximidoyl chloride;hydrochloride Chemical compound Cl.C1CCCCN1CC(O)CON=C(Cl)C1=CC=CC=C1 HPNBPCVAJIMXAR-UHFFFAOYSA-N 0.000 description 1
- UFAFWRGJORGNKN-UHFFFAOYSA-N n-[3-(diethylamino)-2-hydroxypropoxy]pyridine-3-carboximidoyl chloride;hydrochloride Chemical compound Cl.CCN(CC)CC(O)CON=C(Cl)C1=CC=CN=C1 UFAFWRGJORGNKN-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- BSPDRIFPGZTCND-UHFFFAOYSA-N pyridine-3-carboximidoyl chloride Chemical compound ClC(=N)C1=CC=CN=C1 BSPDRIFPGZTCND-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
- C07C249/12—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reactions not involving the formation of oxyimino groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/02—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by halogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9700699A HU220971B1 (hu) | 1997-04-03 | 1997-04-03 | Eljárás 0-(3-amino-2-hidroxi-propil)-hidroximsav-halogenidek előállítására |
| PCT/HU1997/000082 WO1998043948A1 (en) | 1997-04-03 | 1997-12-05 | Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK134899A3 true SK134899A3 (en) | 2000-06-12 |
Family
ID=89994956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1348-99A SK134899A3 (en) | 1997-04-03 | 1997-12-05 | Process for preparing o-(3-amino-2-hydroxy-propyl)hydroxymic acid halides |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US6180787B1 (hr) |
| EP (1) | EP0975585A1 (hr) |
| JP (1) | JP2001521498A (hr) |
| KR (1) | KR20010005943A (hr) |
| CN (1) | CN1251574A (hr) |
| AP (1) | AP9901646A0 (hr) |
| AR (1) | AR012308A1 (hr) |
| AU (1) | AU737994B2 (hr) |
| BG (1) | BG63116B1 (hr) |
| BR (1) | BR9714717A (hr) |
| CA (1) | CA2285360A1 (hr) |
| CO (1) | CO4940491A1 (hr) |
| EA (1) | EA199900899A1 (hr) |
| EE (1) | EE03868B1 (hr) |
| EG (1) | EG22104A (hr) |
| HR (1) | HRP980175A2 (hr) |
| HU (1) | HU220971B1 (hr) |
| ID (1) | ID20016A (hr) |
| IL (1) | IL132048A0 (hr) |
| IS (1) | IS5174A (hr) |
| MA (1) | MA26143A1 (hr) |
| NO (1) | NO312027B1 (hr) |
| NZ (1) | NZ500020A (hr) |
| PE (1) | PE83299A1 (hr) |
| PL (1) | PL336072A1 (hr) |
| SK (1) | SK134899A3 (hr) |
| TN (1) | TNSN98046A1 (hr) |
| TR (1) | TR199902207T2 (hr) |
| TW (1) | TW455573B (hr) |
| UY (1) | UY24945A1 (hr) |
| WO (1) | WO1998043948A1 (hr) |
| YU (1) | YU49499A (hr) |
| ZA (1) | ZA982755B (hr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9900475D0 (en) * | 1999-02-26 | 1999-04-28 | Biorex Kutato Fejlesztoe Kft | O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component |
| PL371251A1 (en) | 2002-01-11 | 2005-06-13 | Biorex Kutato Es Fejlesztö Rt. | Carboxamidine derivatives and their use in the treatment of vascular diseases |
| HUP0303584A3 (en) | 2003-10-30 | 2009-12-28 | Cytrx Corp | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
| SI2794559T1 (sl) * | 2011-12-23 | 2016-07-29 | Akzo Nobel Chemicals International B.V. | Dušik vsebujoče spojine, uporabne za izdelavo papirja |
| NZ700848A (en) * | 2012-06-14 | 2016-08-26 | Novartis Ag | Azetidinium-containing copolymers and uses thereof |
| CN103804309B (zh) * | 2012-11-09 | 2019-08-02 | 广州喜鹊医药有限公司 | 一种氯肟类化合物及其制备方法和在制药中的应用 |
| EP4247792A1 (en) | 2020-11-19 | 2023-09-27 | Zevra Denmark A/S | Processes for preparing arimoclomol citrate and intermediates thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU207305B (en) * | 1988-03-23 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Improved process for producing amidoxime derivatives |
| HU207988B (en) * | 1988-10-20 | 1993-07-28 | Biorex Kutato Fejlesztoe Kft | Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components |
| HUT54347A (en) * | 1989-01-10 | 1991-02-28 | Chinoin Gyogyszer Es Vegyeszet | Improved process for producing amidoximes |
-
1997
- 1997-04-03 HU HU9700699A patent/HU220971B1/hu not_active IP Right Cessation
- 1997-12-05 JP JP54132298A patent/JP2001521498A/ja active Pending
- 1997-12-05 AU AU54055/98A patent/AU737994B2/en not_active Ceased
- 1997-12-05 TR TR1999/02207T patent/TR199902207T2/xx unknown
- 1997-12-05 EA EA199900899A patent/EA199900899A1/ru unknown
- 1997-12-05 EP EP97947819A patent/EP0975585A1/en not_active Withdrawn
- 1997-12-05 WO PCT/HU1997/000082 patent/WO1998043948A1/en not_active Application Discontinuation
- 1997-12-05 US US09/402,267 patent/US6180787B1/en not_active Expired - Fee Related
- 1997-12-05 NZ NZ500020A patent/NZ500020A/en unknown
- 1997-12-05 SK SK1348-99A patent/SK134899A3/sk unknown
- 1997-12-05 KR KR1019997009020A patent/KR20010005943A/ko not_active Application Discontinuation
- 1997-12-05 CA CA002285360A patent/CA2285360A1/en not_active Abandoned
- 1997-12-05 EE EEP199900438A patent/EE03868B1/xx not_active IP Right Cessation
- 1997-12-05 CN CN97182087A patent/CN1251574A/zh active Pending
- 1997-12-05 AP APAP/P/1999/001646A patent/AP9901646A0/en unknown
- 1997-12-05 BR BR9714717-6A patent/BR9714717A/pt not_active Application Discontinuation
- 1997-12-05 PL PL97336072A patent/PL336072A1/xx unknown
- 1997-12-15 YU YU49499A patent/YU49499A/sh unknown
-
1998
- 1998-03-30 MA MA25016A patent/MA26143A1/fr unknown
- 1998-03-31 EG EG36098A patent/EG22104A/xx active
- 1998-04-01 ZA ZA982755A patent/ZA982755B/xx unknown
- 1998-04-02 UY UY24945A patent/UY24945A1/es not_active IP Right Cessation
- 1998-04-02 PE PE1998000247A patent/PE83299A1/es not_active Application Discontinuation
- 1998-04-02 TN TNTNSN98046A patent/TNSN98046A1/fr unknown
- 1998-04-02 AR ARP980101495A patent/AR012308A1/es not_active Application Discontinuation
- 1998-04-03 CO CO98018891A patent/CO4940491A1/es unknown
- 1998-04-03 ID IDP980507A patent/ID20016A/id unknown
- 1998-04-03 HR HRP9700699A patent/HRP980175A2/hr not_active Application Discontinuation
- 1998-04-07 TW TW087105087A patent/TW455573B/zh not_active IP Right Cessation
-
1999
- 1999-09-10 IS IS5174A patent/IS5174A/is unknown
- 1999-09-23 IL IL13204899A patent/IL132048A0/xx unknown
- 1999-09-23 NO NO19994628A patent/NO312027B1/no not_active IP Right Cessation
- 1999-11-02 BG BG103847A patent/BG63116B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2885266B1 (en) | Process for the preparation of (2z,5z)-5-(3-chloro-4-((r)-2,3-dihydroxypropoxy)benzylidene)-2-(propylimino)-3-(o-tolyl)thiazolidin-4-one and intermediate used in said process | |
| LU84561A1 (fr) | 2-(4-((4,4,-dialcoyl-2,6-piperidinedione-1-yl)butyl)-1-piperazinyl)pyrimidines | |
| EA015801B1 (ru) | Оптически активные карбаматы, способ их получения и их применение в качестве фармацевтических промежуточных соединений | |
| US7868207B2 (en) | Process for producing 1-(3,4-dichlorobenzyl)-5-octylbiguanide or a salt thereof | |
| OA10694A (en) | Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine. | |
| SK134899A3 (en) | Process for preparing o-(3-amino-2-hydroxy-propyl)hydroxymic acid halides | |
| EP2847183B1 (de) | Verfahren zur herstellung von triazol-verbindungen | |
| UA56269C2 (uk) | Спосіб одержання похідних тіазолідиндіону | |
| US20060052613A1 (en) | 1-alkyl-3-aminoindazoles | |
| US5104992A (en) | Method of preparing 2-phenyl benezothriazoles | |
| CZ205599A3 (cs) | Způsob výroby pyridin-2,3-dikarboxylátových sloučenin a jejich meziprodukty | |
| JP4161290B2 (ja) | ピリミジニルアルコール誘導体の製造方法及びその合成中間体 | |
| EP0522914A1 (fr) | Dérivés de 2-pipéridinylpyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique | |
| US3992398A (en) | Process for the production of 1,2,4-triazole derivatives | |
| CZ336399A3 (cs) | Způsob přípravy halogenidů 0-(3-amino-2- hydroxypropyl)hydroxamové kyseliny | |
| HU207709B (en) | Process for producing n-/n-propyl/-n-/2-/2,4,6-trichloro-phenoxy/-ethyl/-amine | |
| JP2024058272A (ja) | １－アルキル－５－ヒドロキシピラゾールの製造方法 | |
| JPH07206783A (ja) | α，α−ジメチルベンジルアミン類の製造法 | |
| CS274423B2 (en) | Method of 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl) butyl)-8-aza-spiro (4,5)-decane-7,9-dione preparation | |
| MXPA99009046A (en) | Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides | |
| JPH03200747A (ja) | Ｎ−メチル−４−ｔ−ブチルベンジルアミンの製造法 | |
| JPH0710852B2 (ja) | イソオキサゾリジン誘導体 | |
| FR2693195A1 (fr) | Dérivés de 2-amino-N-[[[(4-aminocarbonyl)pyrimidin-2-yl]amino]alkyl] pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique. | |
| JP2001328983A (ja) | 二置換ニトログアニジンの製造方法 | |
| JP2003342264A (ja) | １−置換−２−アルキルピペラジンの製造方法 |